Lumida
/DMC
⌘K
DMC

DMC

DMC
$29.33USD-0.07%-0.02 today

MARKET CAP

1.4B

P/E (TTM)

FWD P/E

DAY RANGE

$29 – $30

52W RANGE

$3
$30

AI Summary

Stalk
StalkMedium

DMC remains in a Stage 2 advancing phase with intact higher highs and higher lows, but price is currently extended far above its rising EMAs and in extreme overbought territory, making timing unfavorable. Engagement should be deferred until pullbacks into the rising 9/21 EMA zone, where a structurally sound entry can be considered.

  • Del Monte Foods acquisition expected to generate $600M net sales
  • Pineapple and fresh-cut segments show demand outpacing supply
  • Growth momentum weak: negative growth and revision trends point down
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Del Monte Corporation (NYSE:DMC) is a global producer and distributor of fresh and value-added food products, focusing primarily on fresh fruits and vegetables, including pineapples and bananas. The company has undergone significant strategic shifts, including a recent name change from Fresh Del Monte Produce Inc. and the acquisition of Del Monte Foods, aiming to streamline operations and enhance market presence under a unified brand. This strategic realignment positions Del Monte within a thriving fresh produce sector amidst ongoing challenges in supply chain logistics and cost management, reflecting broader trends in consumer demand for healthy, convenience-oriented food options.

Bull says

  • Del Monte Foods acquisition expected to generate $600M net sales
  • Pineapple and fresh-cut segments show demand outpacing supply
  • Fresh/value-added product margins to expand to 12–14% by 2026
  • Maintains 3% dividend yield and $30M share buybacks
  • Efficient logistics mitigate supply chain disruptions, preserving market share
  • High earnings yield and favorable book-to-price signal valuation upside

Bear says

  • Growth momentum weak: negative growth and revision trends point down
  • Geopolitical tensions inflate logistics costs by $40–45M, squeezing margins
  • Banana crop disease drives margins down to ~4%, raising protection costs
  • Long-term debt rose to $438M, average leverage 1.4× EBITDA
  • Asian market demand in Japan and Korea declining year over year
  • Weak profitability and high short interest reflect investor skepticism

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 07-03-2026bullish

Transcript signals

Bull points

  • Gross profit for the first quarter of 2025 was $92 million compared with $82 million in the prior year, driven by higher net sales in our fresh and value-added product segments, partially offset by higher per unit production, procurement, and distribution costs.
  • Our diluted EPS for the first quarter was $0.64 per share compared with $0.55 in the prior year. Adjusted diluted EPS was $0.63 compared with $0.34 per share last year.
  • Adjusted EBITDA for the first quarter of 2025 was 61 million or 6% of net sales compared with 44 million or 4% in the prior year.

Bear points

  • Net sales were $1,098,000,000 compared with $1,108,000,000 in the prior year, driven by lower net sales in our banana segment, primarily a result of lower sales volume and the negative impact of fluctuations in exchange rates
  • net sales were $364 million compared with $380 million in the prior year, primarily due to lower sales volume and per unit selling prices in Asia due to a combination of lower market demand and excess industry supply.
Read full transcript analysis ›